• X Aguilera, M J Martínez-Zapata, P Hinarejos, M Jordán, J Leal, J C González, J C Monllau, F Celaya, A Rodríguez-Arias, J A Fernández, X Pelfort, and L l Puig-Verdie.
• Orthopedic Surgery and Traumatology Department, Hospital de la Santa Creu i Sant Pau, Sant Antoni Mª Claret 167, 08025, Barcelona, Spain.
• Arch Orthop Trauma Surg. 2015 Jul 1;135(7):1017-25.

IntroductionTranexamic acid (TXA) is becoming widely used in orthopedic surgery to reduce blood loss and transfusion requirements, but consensus is lacking regarding the optimal route and dose of administration. The aim of this study was to compare the efficacy and safety of topical and intravenous routes of TXA with routine hemostasis in patients undergoing primary total knee arthroplasty (TKA).Materials And MethodsWe performed a randomized, multicenter, parallel, open-label clinical trial in adult patients undergoing primary TKA. Patients were divided into three groups of 50 patients each: Group 1 received 1 g topical TXA, Group 2 received 2 g intravenous TXA, and Group 3 (control group) had routine hemostasis. The primary outcome was total blood loss. Secondary outcomes were hidden blood loss, blood collected in drains, transfusion rate, number of blood units transfused, adverse events, and mortality.ResultsOne hundred and fifty patients were included. Total blood loss was 1021.57 (481.09) mL in Group 1, 817.54 (324.82) mL in Group 2 and 1415.72 (595.11) mL in Group 3 (control group). Differences in total blood loss between the TXA groups and the control group were clinically and statistically significant (p < 0.001). In an exploratory analysis differences between the two TXA groups were not statistically significant (p = 0.073) Seventeen patients were transfused. Transfusion requirements were significantly higher in Group 3 (p = 0.005). No significant differences were found between groups regarding adverse events.ConclusionWe found that 1 g of topical TXA and 2 g of intravenous TXA were both safe strategies and more effective than routine hemostasis to reduce blood loss and transfusion requirements after primary TKA.Level Of EvidenceI.

25 keywords...

hide…